InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.52
(
-0.25%
)
US TECH 100
19,418.40
(
0.02%
)
Dow Jones
41,902.95
(
-0.72%
)
Brent Oil
72.68
(
-2.53%
)
Bitcoin
63,147.01
(
-1.74%
)
Post# of 180
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Timetravelerdos

Send PM Follow Ignore
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Timetravelerdos

Re: None

Saturday, 12/12/2020 10:56:53 AM

Saturday, December 12, 2020 10:56:53 AM

Post# of 180
Really good information presented this past week. Read the full article: Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium.

Plus NVTA is the #1 holding in the ARKG portfolio and has a 251% YTD return. The current $56 share price is not scaring people away. I understand taking profits but Invitae is staying in my portfolio.

https://finance.yahoo.com/news/invitae-present-data-supporting-genetic-123000993.html

“Believing in negative thoughts is the single greatest obstruction to success.”
Charles F. Glassman

Statements made are only my opinion. Do your own DD in order to make your own investment decisions.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up